PYCR2 and hepatocellular carcinoma: This aligns with research indicating PYCR1 in tumors such as colorectal cancer, bladder cancer, and gastric cancer, among others [43,44,45], and PYCR2 in colorectal cancer, hepatocellular carcinoma, melanoma, and other cancers [11,46,47].